APC & VLE Therapeutics Recognized with Top Honors at 2024 Pharma Industry Awards

APC and VLE Therapeutics, together known as The Medicine Accelerator, are thrilled to announce their outstanding achievement at the 2024 Pharma Industry Awards, where they won Biotech Company of the Year, Pharma Company of the Year - SME, and the premier Pharma Industry Company of the Year award. Recognizing excellence across the Irish pharmaceutical landscape, the Pharma Industry Awards honor the most innovative and impactful contributions within the sector. APC and VLE’s landmark achievements underscore their industry leadership and dedication to advancing pharmaceutical innovation and reinforces their role as a trusted partner for global leaders in the biopharma industry.

The awards, established in 2014, celebrate outstanding achievements by individuals and organizations that set new standards in the pharmaceutical industry. This year, APC and VLE were shortlisted in eight categories, more than any other nominee, highlighting their comprehensive impact in key areas such as operational excellence, health and safety, supply chain achievement, sustainability, corporate social responsibility, and talent development.

“It is an incredible honor to receive these awards and to be recognized for our commitment to pioneering developments in the pharma community. To have industry experts recognize our progress—whether through our sustainable practices, commitment to diversity and inclusion, the pioneering iAchieve digital platform, or the scaling ambition of our Medicine Accelerator Campus—is deeply gratifying. These wins symbolize our daily commitment to making a global impact, driving our mission forward, and ultimately transforming lives

through science.”

Mark Barrett, CEO and Co-Founder of APC & VLE Therapeutics

The Pharma Industry Awards, hosted with The Irish Times as Communications Partner, gathered Ireland’s leading pharmaceutical and biotech companies, CROs, and innovators, celebrating a shared commitment to excellence in a sector dedicated to advancing global health. Winning these awards highlights APC and VLE’s dedication to best-in-class scientific research and cutting-edge digital technologies which enable breakthrough advancements in therapeutic development and manufacturing and underscores Ireland’s prominent position as a hub for pharmaceutical innovation.

These awards propel APC & VLE forward on their mission to accelerate life-saving therapeutics, solidifying their vision to become a global leader in pharmaceutical digitalization and manufacturing. Through initiatives like the iAchieve platform, APC and VLE exemplify a future where medicines reach patients faster and more effectively, setting a new standard in pharmaceutical R&D.